This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis
Bone Marrow Transplantation Open Access 05 June 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Cooper LT, Berry GJ, Shabetai R . Idiopathic giant-cell myocarditis: natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997; 336: 1860–1866.
Sakata-Yagimoto M, Kanda Y, Nakagawa N, Asano-Mori Y, Kandabashi K, Izutsu K et al. Post-transplant complication: Predictors for severe cardiac complications after hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 33: 1043–1047.
Bravermann AC, Antin JH, Plappert MT, Cook EF, Lee RT . Cyclophosphamide cardiotoxicity in bone marrow transplantation: a retrospective evaluation of new dosing regimens. J Clin Oncol 1991; 9: 1215–1223.
Shan K, Lincoff AM, Young JB . Anthracycline-induced cardiotoxicity. Ann Intern Med 1996; 125: 47–58.
Truica CI, Hansen CH, Garvin DF, Meehan KR . Idiopathic giant cell myocarditis after autologous hematopoietic stem cell transplantation and interleukin-2 immunotherapy. Cancer 1998; 83: 1231–1236.
Platzbecker U, Klingel K, Thiede C, Freiberg-Richte J, Schuh D, Ehninger G et al. Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin. Bone Marrow Transplant 2001; 27: 107–109.
Ankersmit HJ, Ullrich R, Moser B, Hoetzenecker K, Hacker S, German P et al. Recovery from giant cell myocarditis with ECMO support and utilization of polyclonal antithymocyte globulin: a case report. Thorac Cardiovasc Surg 2006; 54: 278–280.
Yabe H, Yabe M, Kato S, Kimura M, Iwaki K . Increased number of D8+CD11+, CD8+CD11− and CD8+Leu7+ cells in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1990; 5: 295–300.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yabe, M., Ishiguro, H., Yasuda, Y. et al. Fatal giant cell myocarditis after allogeneic bone marrow transplantation. Bone Marrow Transplant 41, 93–94 (2008). https://doi.org/10.1038/sj.bmt.1705869
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705869
This article is cited by
-
Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis
Bone Marrow Transplantation (2017)
-
Idiopathic giant cell myocarditis and cardiac sarcoidosis
Heart Failure Reviews (2013)
-
Polymyositis and myocarditis after donor lymphocyte infusion
International Journal of Hematology (2009)